| The Manhattan Adult Attention Deficit Disorder Support Group |
| www.maaddsg.org |
|
Our Goal Is To Offer Support And
Information To Adults In New York City And The Surrounding Communities With ADD/ADHD |
| We Are Not "Lazy, Crazy, Or Stupid" |
| ~~~~~~~~~~~~~~ |
| Coping Strategies |
| Dr. Jeffrey Cohen; |
| Associate Dean for
Responsible Conduct of Research, Weill Medical College of Cornell University; former associate director of education, Office for Human Research Protections, US Department of Health and Human Services why: Each year, thousands of patients enroll in studies designed to test experimental drugs, devices, or other therapies; or to learn more about specific ailments (including ADD). Such "clinical trials" -- medical or behavioral studies which use human subjects -- constitute a resource, but one that is not often discussed and not always understood. Who designs these studies? Who approves them? Who pays for them? Why are they run the way they are? Who gets picked to participate, and for what reasons? For volunteers, what are the possible risks? How might they -- or others -- benefit? Before signing up, what questions should they ask?* How might they (or we) distinguish between a drug study, an imaging study, or a genetic study? Walking us through some of these ABCs will be Dr. Jeffrey M. Cohen of New York's Weill/Cornell medical school. Dr. Cohen earned his doctorate, in experimental psychology, from Northern Illinois University. For 30 years, in Albany and Washington and New York, he has worked in the field of research oversight and patient protection. His efforts have included public outreach work; database management; and the interpretation of federal guidelines. Dr. Cohen has discussed these topics at a variety of public forums, and has served as president of the Applied Research Ethics National Association (ARENA). *For more: www.maaddsg.org/about-clinical-trials.htm and www.maaddsg.org/Clinical_Trials_Studies.htm. |